Abstract
For simplifying analytic process, the preceded few fractions of the chromato-graphed effluent were put aside and stored for later studies. Their extremely high protein content were conotative of the existence of a polymer deriving most probably from the abve albumin-analogue. For convenience sake, we wish to use “albuminoid” and “globulinoid” respectively. The MW of albuminoid was 66.2 kd; wehreas that of an albumin is 66.0 kd; almost the same values with a similar pI value. Drop of blood-albumin level of patients might be ascribable to the elaboration of albuminoid by the organism, i.e., viridans group streptococci; at least two species take the role, e.g., S. sanguis, S. parasanguis or S. oralis. They usually cooperate for this in situ amino acid and/or peptid synthesis. Thus, the relation between patient (host) and organism (parasite) is conpetitive for depriving these raw materials. Things might be similar in case of globulinoid synthesis; raw materials must be deprived by the organism: rapid improvement of clinical symptoms brought about after gamma-globulin therapy must be due to its genuin complementary efficacy. General views cited above were based on our data on all the stage of molucular evolution, from a precursor peptide through albuminoid up to globulinoid. Data might be applicable to members of similar genom family.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyamoto, Y., Tanaka, J. “Cytoviridin(e)”, A Novel Etiologic Metabolite Characterizing Kawasaki Disease is an Analogue of Human Serum Albumin; Cytotoxic Proteinase Blocking Cyto-chroms and Aggregating Mammalian Thrombocyte. Pediatr Res 53, 169 (2003). https://doi.org/10.1203/00006450-200301000-00092
Issue Date:
DOI: https://doi.org/10.1203/00006450-200301000-00092